Ophthalmic Angiography (Fluorescein and Indocyanine Green)
J15 · Effective Oct 1, 2015
21 active Medicare policies list H44.23, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
7 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of H44.23 |
|---|---|---|
| Extended Ophthalmoscopy | Not recorded | Covered |
| Fluorescein Angiography | Not recorded | Covered |
| Fundus Photography | Not recorded | Covered |
| Medically Necessary Optical Hardware | Not recorded | Covered |
| Visual Field Testing | Not recorded | Covered |
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2025
National · Effective Jan 15, 2026
National · Effective Oct 1, 2025
J6 · Effective Oct 1, 2025
National · Effective Nov 6, 2025
J6 · Effective Oct 1, 2025
National · Effective Oct 1, 2025
J9 · Effective Oct 1, 2025
| Policy | Effective | Status of H44.23 |
|---|
| Vascular Endothelial Growth Factor Inhibitors for Ocular Indications | Feb 20, 2024 | Covered |
|---|---|---|
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |